Browse by all authors Browse By Author Name - Van+Rhee,+F

Browse Results (3 results found)

Subscribe to the RSS feed for this result setSubscribe to the RSS feed for this result set

  Abstract Views File Downloads Thomson Reuters Web of Science Citation Count Scopus Citation Count Altmetric Score
Fassas, A. B. T., Sawyer, J., McCoy, J., Anaissie, E. J., Lee, C. K., Talamo, G., Wendling, C., Zangari, M., Van Rhee, F., Thertulien, R., Tricot, G. J. and Barlogie, B. (2003). Absence of hypodiploidy and/or chromosome 13 abnormalities (hypo-CA13) confers superior survival in multiple myeloma (MM) patients (pts): Interim analysis of total therapy (TT) II trial. In: 45th Annual Meeting of the American Society of Hematology, San Diego CA, United States, (684A-684A). 6-9 December 2003. 62   0
Singhal, S., Henslee-Downey, P. J., Powles, R., Chiang, K. Y., Godder, K., Treleaven, J., Kulkarni, S., van Rhee, F., Sirohi, B., Pinkerton, C. R., Meller, S., Jovanovic, B. and Mehta, J. (2003) Haploidentical vs autologous hematopoietic stem cell transplantation in patients with acute leukemia beyond first remission. Bone marrow transplantation, 31 10: 889-895. doi:10.1038/sj.bmt.1704031 37   Cited 13 times in Scopus13 0
Anaissie, E. J., Jacobson, J., Fassas, A. B., Zangari, M., Thertulien, R., VanRhee, F., Talamo, G., Tricot, G., Wendling, C., Davis, C. K., Hollmig, K. and Barlogie, B. (2003). Safety of total therapy II with or without thalidomide (THAL) for newly diagnosed myeloma: A study of 475 consecutive patients. In: 45th Annual Meeting of the American Society of Hematology, San Diego CA, United States, (454A-454A). 6-9 December 2003. 26   0